Drug Delivery
11 articles on Drug Delivery, researched and written by the Shotlee Editorial Team from primary sources.
Novo Nordisk's Semaglutide Implant Could Replace Ozempic Injections
Novo Nordisk and Vivani Medical are developing a semaglutide implant that could eliminate the need for weekly injections. Here is everything to know about the technology.
6 min read
Ozempic's Oral Twin: A Needle-Free Weight Loss Revolution Arrives?
A new era in weight management may be dawning as an oral medication, mirroring the efficacy of popular injectables like Ozempic, is poised for approval. This development promises a more accessible and convenient path to weight loss for millions.
7 min read
Beyond GLP-1s: Understanding the Peptide Therapy Health Craze
Peptide therapy is rapidly gaining traction far beyond the well-known GLP-1 medications. This deep dive explores the science, the 'health-maxing' movement, supply chain complexities, and the crucial regulatory landscape shaping the future of these powerful compounds.
7 min read
Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever
Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.
8 min read
Beyond the Injection: The Future of GLP-1 Therapies
GLP-1 receptor agonists have revolutionized weight loss and diabetes management, but researchers are continuously seeking ways to enhance their delivery. This article delves into cutting-edge advancements, from nanocarriers to microneedles, aiming to make these powerful therapies more effective, tolerable, and convenient.
7 min read
West Pharmaceuticals Expands Dublin Site, Creates 330 Jobs for GLP-1
West Pharmaceuticals is expanding its Dublin manufacturing site, adding 330 high-skilled jobs to meet surging demand for drug delivery solutions in diabetes and obesity treatments. The 165,000 square foot facility upgrade focuses on containment and delivery systems for injectables, including next-generation GLP-1 therapies like those used in semaglutide drugs. This move strengthens Ireland's role in global metabolic health supply chains.
5 min read
Zydus Launches Semaglutide in Reusable Pen After Patent Expiry: Prices to Fall
Zydus Lifesciences is set to revolutionize semaglutide access in India with a reusable adjustable pen device after the patent expires on March 20. Brands like SEMAGLYN™, MASHEMA™, and ALTERMET™ promise easier dosing and lower prices around ₹3,500-4,000 per month. This move could expand GLP-1 therapy for Type 2 diabetes and obesity amid rising demand.
5 min read
Strategic Acquisitions and Partnerships in the GLP-1 Agonists Market: An Overview of Recent Trends
The global GLP-1 agonists market is anticipated to reach over USD 260.1 billion by 2034, demonstrating a CAGR of 19.9% during the forecast period. This growth is driven by innovations in diabetes, obesity, and cardiovascular disease treatments, though high costs and administration challenges remain.
4 min read
Peptide Therapeutics Market to Hit USD 82.19 Billion by 2032 Amid Rising Demand for Oncology Medicines: SNS Insider
The global Peptide Therapeutics Market is experiencing substantial growth, projected to reach USD 82.19 billion by 2032. This expansion is fueled by the increasing need for specialized medications, particularly in oncology and metabolic diseases. The U.S. market is expected to reach USD 35.71 billion by 2032.
4 min read
Mounjaro Delivered: UAE App Introduces Weight-Loss Medication Delivery
A prominent home services company in the UAE has begun delivering weight-loss medications, indicating the sustained popularity of GLP-1 drugs. This move raises discussions about accessibility and safety when obtaining prescription drugs online.
4 min read
Oral Proteins & Peptides Market to Reach USD 47.2 Billion Globally by 2035, Exhibiting 15.3% CAGR - TMR Study
The global market for oral proteins and peptides is experiencing rapid expansion, with projections estimating a value of US$ 47.2 billion by 2035. This growth, driven by increasing demand for peptide-based therapeutics and advancements in delivery technologies, signifies a dynamic shift in the pharmaceutical and nutraceutical landscape.
6 min read